Credit Agricole
RDY icon

Credit Agricole’s Dr. Reddy's Laboratories RDY Stock Holding History

Credit Agricole’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30
Closed -$477 – 1327
2024
Q3 		$477 Hold
30
– – ﹤0.01% 1263
2024
Q2 		$457 Hold
30
– – ﹤0.01% 1089
2024
Q1 		$425 Sell
30
-580
-95% -$8.47K ﹤0.01% 928
2023
Q4 		$8.49K Sell
610
-2,070
-77% -$27.7K ﹤0.01% 849
2023
Q3 		$35.8K Sell
2,680
-995
-27% -$13.5K ﹤0.01% 801
2023
Q2 		$46.4K Buy
3,675
+205
+6% +$2.39K ﹤0.01% 542
2023
Q1 		$39.5K Buy
+3,470
New +$37.5K ﹤0.01% 520
2017
Q4 		– Sell
-104,175
Closed -$743K – 911
2017
Q3 		$743K Buy
104,175
+39,175
+60% +$282K ﹤0.01% 1157
2017
Q2 		$548K Hold
65,000
– – ﹤0.01% 1198
2017
Q1 		$522K Hold
65,000
– – ﹤0.01% 1365
2016
Q4 		$589K Hold
65,000
– – ﹤0.01% 1200
2016
Q3 		$603K Hold
65,000
– – ﹤0.01% 1291
2016
Q2 		$666K Buy
+65,000
New +$596K ﹤0.01% 1110
2016
Q1 		– Sell
-118,000
Closed -$1.09M – 1353
2015
Q4 		$1.09M Sell
118,000
-82,000
-41% -$898K 0.01% 984
2015
Q3 		$2.56M Sell
200,000
-853,500
-81% -$10.6M 0.01% 755
2015
Q2 		$11.7M Sell
1,053,500
-143,000
-12% -$1.58M 0.05% 363
2015
Q1 		$13.7M Buy
1,196,500
+189,000
+19% +$2M 0.06% 342
2014
Q4 		$9.7M Sell
1,007,500
-555,000
-36% -$5.84M 0.04% 445
2014
Q3 		$16.4M Sell
1,562,500
-65,000
-4% -$611K 0.07% 316
2014
Q2 		$14M Buy
1,627,500
+135,685
+9% +$1.14M 0.06% 353
2014
Q1 		$13.1M Buy
1,491,815
+565,315
+61% +$4.92M 0.05% 385
2013
Q4 		$7.6M Sell
926,500
-351,000
-27% -$2.78M 0.03% 524
2013
Q3 		$9.65M Buy
+1,277,500
New +$9.29M 0.04% 431

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Credit Agricole's RDY Position: Q4 2024 in Review

Credit Agricole sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 30 shares — an estimated $477 sold.

Credit Agricole first reported a position in RDY in Q3 2013 and held it in 23 quarters. The position peaked at $16.4M in Q3 2014. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • Credit Agricole reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • Credit Agricole sold 30 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $477.
  • Credit Agricole first reported a position in Dr. Reddy's Laboratories in Q3 2013 and held it in 23 quarters.
  • Credit Agricole's Dr. Reddy's Laboratories position peaked at $16.4M in Q3 2014.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Credit Agricole's 13F filing for Q4 2024, filed 14 Feb 2025.